KALA BIO, Inc. — Director's Dealing 2025

Sep 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KALA BIO, Inc. (KALA)
CIK: 0001479419
Period of Report: 2025-08-29

Reporting Person: Bazemore Todd (Director, SEE REMARKS)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-29	Stock Option (right to buy)	$11.22	A	180000	Acquired	2035-08-28	Common Stock (180000)	Direct

Footnotes

F1: This option was granted on August 29, 2025 and vests over four years beginning on the vesting commencement date of August 29, 2025, with 1/48th of the shares underlying the option vesting at the end of each successive one-month period thereafter until August 29, 2029, subject to the Reporting Person's continued service.